Our Solutions

Platform Technology

The innovative methodologies and applications of our natural C-Terminal Peptides, and Reverse PEGylation platform technologies enable us to create next generation, longer acting and more effective therapeutic peptides and proteins to attack a myriad of diseases and improve patients’ quality of life. In addition, our AntagoNAT technology allows us to develop treatments for unmet needs in the area of genetic disease. The Claros point of care device enables rapid laboratory test results be obtained at doctors' offices, as well as, emergency and operating rooms.

Learn More

High Potency Compounds

Our subsidiary, EirGen Pharma (Eirgen), is a leading developer and commercial supplier of specialty medicines to the global market. EirGen provides versatile, price effective and efficient solutions to pharma partners seeking to collaborate in pharma healthcare. EirGen is a trusted supplier of high quality, safe and reliable lifesaving high containment medicines in more than 50 countries worldwide.

Branded Generics in Latin America

Our subsidiaries in Central and South America commercialize and distribute hundreds of branded medical products in the Latin American region. These companies are focused on delivering value to our customers through superior quality, attentive service, and affordable prices.

Animal Health

In Europe and Latin America, we offer thoughtfully designed veterinary care products that help promote the healthy, active lifestyles of pets and their owners. Additionally, we are developing a line of oncology products based on our expertise of manufacturing high potency product at our Irish based subsidiary, EirGen Pharma.